|Bid||0.00 x 1200|
|Ask||0.00 x 1100|
|Day's Range||366.12 - 372.63|
|52 Week Range||271.28 - 384.87|
|Beta (5Y Monthly)||0.69|
|PE Ratio (TTM)||41.10|
|Earnings Date||Dec 10, 2020|
|Forward Dividend & Yield||2.80 (0.76%)|
|Ex-Dividend Date||Oct 29, 2020|
|1y Target Est||368.07|
To the question of what's the most feared competitor in retail, the answer is simple. Amazon (NASDAQ: AMZN) has demonstrated time and again its desire to disrupt as many corners of the retail industry has possible, and Wall Street tends to give the tech giant a wide berth. For instance, when Amazon acquired Whole Foods Market in 2017, supermarket stocks fell broadly, including Sprouts, Supervalu, Walmart, and Costco (NASDAQ: COST), as investors feared that the industry was about to experience the "Amazon effect."
Discount retailer Costco has started to sell coronavirus testing kits on its website Friday. Priced at $129.99 and $139.99, the retailer's 'Covid-19 Saliva PCR Test Kits' claim to be the gold standard testing method with the most accurate sensitivity and specificity currently on the market, according to the website. The at-home, self-administered saliva tests come without a nasal swab which has been widely used for testing in the country.
Under the current circumstances, people are exhibiting a preference for discount stores for essentials or other daily purchases. Apparently, Costco (COST) has emerged as viable option for them.